ChartMill assigns a Buy % Consensus number of 76% to SNCE. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-01-30 | Baird | Downgrade | Outperform -> Neutral |
| 2024-01-29 | Craig-Hallum | Downgrade | Buy -> Hold |
| 2023-03-07 | Baird | Maintains | Outperform |
| 2022-11-14 | William Blair | Downgrade | Outperform -> Market Perform |
| 2022-11-14 | Cowen & Co. | Maintains | Outperform |
| 2022-06-07 | Craig-Hallum | Initiate | Buy |
| 2021-11-01 | Lake Street | Initiate | Buy |
| 2021-11-01 | William Blair | Initiate | Outperform |
| 2021-11-01 | Baird | Initiate | Outperform |
| 2021-10-22 | Cowen & Co. | Initiate | Outperform |
10 analysts have analysed SNCE and the average price target is 14.11 USD. This implies a price increase of 145.39% is expected in the next year compared to the current price of 5.75.
The consensus rating for SCIENCE 37 HOLDINGS INC (SNCE) is 76 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering SCIENCE 37 HOLDINGS INC (SNCE) is 10.